# A Trial of APPA in the Treatment of Knee Osteoarthritis

> **NCT04657926** · PHASE2 · COMPLETED · sponsor: **AKL Research and Development** · enrollment: 152 (actual)

## Conditions studied

- Osteoarthritis

## Interventions

- **DRUG:** APPA
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04657926
- **Lead sponsor:** AKL Research and Development
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-09
- **Primary completion:** 2021-09-30
- **Final completion:** 2021-10-01
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2021-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04657926

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04657926, "A Trial of APPA in the Treatment of Knee Osteoarthritis". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT04657926. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*